Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Quintiles Receives Increasing Number of Orders on ECG Analysis Services
May 21, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
May 21, 2007
- Korosho Continues Hearings to Increase Price Agreement Rates
May 21, 2007
- SURVEY／Dry Eyes Most Common Health Problem: Healthclick
May 21, 2007
- Tamiflu Jumps to Top Position: Rep Track
May 21, 2007
- Wyeth Works to Eliminate "Drug Lag" with Strong R&D Pipeline
May 21, 2007
- BUSINESS NEWS IN BRIEF
May 21, 2007
- Takeda: Strong Growth in Sales, Profits with 49.3% of Sales Overseas
May 21, 2007
- 5-Year Strategy for Innovative Drug Discovery Approved at Gov't-Private Sector Dialogue
May 21, 2007
- DSP: Combined Sales of 4 Mainstay Products Exceed \100 Bil.
May 21, 2007
- JPMA Calls For Prices Commensurate with Value during Patent Life
May 21, 2007
- MPC: Profits Up Despite 3.7% Fall in Sales
May 21, 2007
- REGULATORY NEWS IN BRIEF
May 21, 2007
- Tanabe Seiyaku: Strong Growth in Sales of Remicade Drives Business
May 21, 2007
- Latest Data from Enbrel All-Patient Surveillance Announced
May 21, 2007
- Santen: Strong Growth in Overseas Sales Drives Business
May 21, 2007
- Number of JP Drugs to Increase by 84
May 21, 2007
- Teijin: Pharm. Sales Up 7.1% to \113.1 Bil.
May 21, 2007
- Nippon Shinyaku Establishes Technology to Manufacture Long RNA Oligomers
May 21, 2007
- 6 Tokyo Prefectural Hospitals to Reduce Number of Drugs Used
May 14, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…